Bolt Biotherapeutics, Inc.
BOLT
$0.365
-$0.005-1.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.99% | 6.65% | -17.38% | 36.33% | 10.47% |
| Total Depreciation and Amortization | -8.78% | -4.76% | -0.22% | -1.93% | 1.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.46% | -22.44% | 43.32% | -12.85% | -30.76% |
| Change in Net Operating Assets | -177.71% | 78.53% | 242.47% | 8.55% | 298.84% |
| Cash from Operations | -1.16% | 16.62% | -6.82% | 28.41% | 20.54% |
| Capital Expenditure | 100.00% | 75.15% | -- | -- | 96.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.66% | 32.82% | 32.26% | -64.81% | -4.84% |
| Cash from Investing | -22.63% | 35.39% | 32.57% | -64.81% | -3.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.64% | -- | -46.26% | -- | -26.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -72.64% | -- | -46.26% | -- | -26.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.45% | 177.54% | 240.07% | -217.10% | 220.17% |